48.67
-0.44 (-0.90%)
Previous Close | 49.11 |
Open | 48.91 |
Volume | 481,584 |
Avg. Volume (3M) | 543,550 |
Market Cap | 2,380,722,176 |
Price / Sales | 3.81 |
Price / Book | 1.13 |
52 Weeks Range | |
Earnings Date | 11 Nov 2024 - 15 Nov 2024 |
Profit Margin | -23.66% |
Operating Margin (TTM) | -5.81% |
Diluted EPS (TTM) | -2.83 |
Quarterly Revenue Growth (YOY) | 4.10% |
Total Debt/Equity (MRQ) | 3.59% |
Current Ratio (MRQ) | 4.78 |
Return on Assets (TTM) | -1.59% |
Return on Equity (TTM) | -6.64% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Azenta, Inc. | Bearish | Bearish |
Stockmoo Score
Analyst Consensus | 1.0 |
Insider Activity | 2.0 |
Price Volatility | 1.0 |
Technical Moving Averages | -1.0 |
Technical Oscillators | -0.5 |
Average | 0.50 |
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Growth |
% Held by Insiders | 2.24% |
% Held by Institutions | 112.78% |
52 Weeks Range | ||
Price Target Range | ||
High | 55.00 (Needham, 13.01%) | Buy |
Median | 52.50 (7.87%) | |
Low | 50.00 (Evercore ISI Group, 2.73%) | Hold |
Average | 52.50 (7.87%) | |
Total | 1 Buy, 1 Hold | |
Avg. Price @ Call | 46.01 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Needham | 13 Nov 2024 | 55.00 (13.01%) | Buy | 44.51 |
Evercore ISI Group | 01 Oct 2024 | 50.00 (2.73%) | Hold | 47.50 |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
CORNOG WILLIAM L | 40.37 | - | 12,500 | 504,625 |
HIRSCH DIDIER | 40.37 | - | 1,000 | 40,370 |
HUGHES VIOLETTA | 41.51 | - | 6,921 | 287,291 |
JOSEPH JASON | 41.51 | - | 13,841 | 574,540 |
MADAUS MARTIN D | 40.91 | - | 4,940 | 202,095 |
MAROTTA JOHN | 40.93 | - | 97,589 | 4,035,672 |
PIROGOVA OLGA | 41.51 | - | 10,381 | 430,915 |
WANG DAVID DONG | 41.51 | - | 8,651 | 359,103 |
ZHOU GINGER | 41.51 | - | 8,651 | 359,103 |
Aggregate Net Quantity | 164,474 | |||
Aggregate Net Value ($) | 6,793,714 | |||
Aggregate Avg. Buy ($) | 41.09 | |||
Aggregate Avg. Sell ($) | - |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
MADAUS MARTIN D | Director | 19 Nov 2024 | Buy (+) | 4,940 | 40.91 | 202,095 |
MAROTTA JOHN | Officer | 19 Nov 2024 | Buy (+) | 1,250 | 40.91 | 51,138 |
HIRSCH DIDIER | Director | 18 Nov 2024 | Buy (+) | 1,000 | 40.37 | 40,370 |
CORNOG WILLIAM L | Director | 18 Nov 2024 | Buy (+) | 12,500 | 40.37 | 504,625 |
MAROTTA JOHN | Officer | 18 Nov 2024 | Buy (+) | 12,717 | 40.37 | 513,385 |
HUGHES VIOLETTA | Officer | 15 Nov 2024 | Acquired (+) | 6,921 | 41.51 | 287,291 |
ZHOU GINGER | Officer | 15 Nov 2024 | Acquired (+) | 8,651 | 41.51 | 359,103 |
WANG DAVID DONG | Officer | 15 Nov 2024 | Acquired (+) | 8,651 | 41.51 | 359,103 |
PIROGOVA OLGA | Officer | 15 Nov 2024 | Acquired (+) | 10,381 | 41.51 | 430,915 |
JOSEPH JASON | Officer | 15 Nov 2024 | Acquired (+) | 13,841 | 41.51 | 574,540 |
MAROTTA JOHN | Officer | 15 Nov 2024 | Acquired (+) | 83,622 | 41.51 | 3,471,149 |
Show more |
Date | Type | Details |
---|---|---|
19 Nov 2024 | Announcement | Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 |
14 Nov 2024 | Announcement | Azenta to Participate in Stephens Annual Investment Conference |
12 Nov 2024 | Announcement | Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO |
04 Nov 2024 | Announcement | Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value |
04 Nov 2024 | Announcement | Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast |
30 Oct 2024 | Announcement | Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test |
04 Sep 2024 | Announcement | AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO |
5Y Average Dividend Yield | 0.39% |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
02 Dec 2021 | 02 Nov 2021 | 23 Dec 2021 | 0.1 Cash |
02 Sep 2021 | 03 Aug 2021 | 24 Sep 2021 | 0.1 Cash |
03 Jun 2021 | 27 Apr 2021 | 25 Jun 2021 | 0.1 Cash |
04 Mar 2021 | 25 Jan 2021 | 26 Mar 2021 | 0.1 Cash |
03 Dec 2020 | 05 Nov 2020 | 17 Dec 2020 | 0.1 Cash |
03 Sep 2020 | 29 Jul 2020 | 25 Sep 2020 | 0.1 Cash |
04 Jun 2020 | 29 Apr 2020 | 26 Jun 2020 | 0.1 Cash |
05 Mar 2020 | 23 Jan 2020 | 27 Mar 2020 | 0.1 Cash |
05 Dec 2019 | 01 Nov 2019 | 20 Dec 2019 | 0.1 Cash |
05 Sep 2019 | 31 Jul 2019 | 27 Sep 2019 | 0.1 Cash |
06 Jun 2019 | 26 Apr 2019 | 28 Jun 2019 | 0.1 Cash |
28 Feb 2019 | 29 Jan 2019 | 22 Mar 2019 | 0.1 Cash |
06 Dec 2018 | 06 Nov 2018 | 20 Dec 2018 | 0.1 Cash |
06 Sep 2018 | 31 Jul 2018 | 28 Sep 2018 | 0.1 Cash |
31 May 2018 | 30 Apr 2018 | 22 Jun 2018 | 0.1 Cash |
01 Mar 2018 | 31 Jan 2018 | 23 Mar 2018 | 0.1 Cash |
30 Nov 2017 | 08 Nov 2017 | 22 Dec 2017 | 0.1 Cash |
07 Sep 2017 | 01 Aug 2017 | 29 Sep 2017 | 0.1 Cash |
31 May 2017 | 27 Apr 2017 | 23 Jun 2017 | 0.1 Cash |
01 Mar 2017 | 31 Jan 2017 | 24 Mar 2017 | 0.1 Cash |
30 Nov 2016 | 09 Nov 2016 | 23 Dec 2016 | 0.1 Cash |
31 Aug 2016 | 27 Jul 2016 | 23 Sep 2016 | 0.1 Cash |
01 Jun 2016 | 27 Apr 2016 | 24 Jun 2016 | 0.1 Cash |
02 Mar 2016 | - | 24 Mar 2016 | 0.1 Cash |
02 Dec 2015 | 04 Nov 2015 | 22 Dec 2015 | 0.1 Cash |
02 Sep 2015 | 05 Aug 2015 | 25 Sep 2015 | 0.1 Cash |
03 Jun 2015 | 28 Apr 2015 | 26 Jun 2015 | 0.1 Cash |
04 Mar 2015 | 04 Feb 2015 | 27 Mar 2015 | 0.1 Cash |
03 Dec 2014 | 05 Nov 2014 | 26 Dec 2014 | 0.1 Cash |
03 Sep 2014 | 30 Jul 2014 | 26 Sep 2014 | 0.1 Cash |
04 Jun 2014 | 07 May 2014 | 27 Jun 2014 | 0.08 Cash |
05 Mar 2014 | 05 Feb 2014 | 28 Mar 2014 | 0.08 Cash |
04 Dec 2013 | 12 Nov 2013 | 27 Dec 2013 | 0.08 Cash |
04 Sep 2013 | 07 Aug 2013 | 27 Sep 2013 | 0.08 Cash |
Show more |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2021 | 0.400 | 4 | 0.39 |
2020 | 0.400 | 4 | 0.59 |
2019 | 0.400 | 4 | 0.95 |
2018 | 0.400 | 4 | 1.53 |
2017 | 0.400 | 4 | 1.68 |
2016 | 0.400 | 4 | 2.34 |
2015 | 0.400 | 4 | 3.75 |
2014 | 0.360 | 4 | 2.82 |
2013 | 0.160 | 2 | 1.53 |
Show more |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |